The Art of the Myopia Conversation
-
By
-
William Stephen, MTh, OD, FIAOMC
-
March 2, 2026
-
4 min
By
William Stephen, MTh, OD, FIAOMC
March 2, 2026
Ahead of phase 3 myopia push, late clinical-stage biopharmaceutical company takes on Thomas Ruggia as Chief Executive Officer
May 18, 2026
Sharon Bakalash, MD, PhD, CBA, describes how the interdisciplinary pre-ARVO forum explored ways to move AI from concept to clinic.
May 1, 2026
New Contact Lens Update explores safety, benefits, and real-world outcomes of prescribing contact lenses to children
May 15, 2026